Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 Env-Reference-Cited by-同舟云学术

Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 Env

Published:2023-06-27 Issue:7 Volume:32 Page:1497-1509
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Gupta Monisha^ORCID,Canziani Gabriela^ORCID,Ang Charles^ORCID,Mohammadi Mohammadjavad^ORCID,Abrams Cameron F.^ORCID,Yang Derek^ORCID,Smith Amos B.^ORCID,Chaiken Irwin^ORCID

Funder

National Institute of General Medical Sciences

National Institute of Allergy and Infectious Diseases

Pennsylvania Department of Health

NIH Office of the Director

Drexel University

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s00044-023-03092-0.pdf

Reference50 articles.

1. Margolis DM, Archin NM, Cohen MS, Eron JJ, Ferrari G, Garcia JV, et al. Curing HIV: seeking to target and clear persistent infection. Cell. 2020;181:189–206. https://doi.org/10.1016/j.cell.2020.03.005.

2. Thomas J, Ruggiero A, Paxton WA, Pollakis G. Measuring the success of HIV-1 cure strategies. Front Cell Infect Microbiol. 2020;10:134. https://doi.org/10.3389/fcimb.2020.00134.

3. Kim J, Vasan S, Kim JH, Ake JA. Current approaches to HIV vaccine development: a narrative review. J Int AIDS Soc. 2021;24:e25793. https://doi.org/10.1002/jia2.25793.

4. Wang Q, Finzi A, Sodroski J. The conformational states of the HIV-1 envelope glycoproteins. Trends Microbiol. 2020;28:655–67. https://doi.org/10.1016/j.tim.2020.03.007.

5. Vézina D, Gong SY, Tolbert WD, Ding S, Nguyen D, Richard J, et al. Stabilizing the HIV-1 envelope glycoprotein State 2A conformation. J Virol. 2020;95:e01620–20. https://doi.org/10.1128/JVI.01620-20.